1424MO Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma– Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM

Authors :: Daniel Pink
Gabriele Margareta Siegler
Eray Goekkurt
S. Angermeier
Timo Gaiser
H.-G. Kopp
Thomas Zander
Harald Schmalenberg
S-E. Al-Batran
Evaristo Maiello
R.D. Hofheinz
Jochem Potenberg
Disorn Sookthai
Dirk Strumberg
Ulli Simone Bankstahl
Claudia Pauligk
Nils Homann
Michael Schenk
T.O. Götze
F. De Vita
Source :: Annals of Oncology. 31:S901
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
PHASE II/III TRIAL
medicine.medical_specialty
business.industry
Hematology
Perioperative
medicine.disease
language.human_language
Ramucirumab
German
Internal medicine
medicine
language
Adenocarcinoma
business

Full Text Access

Tools